WO2009017104A1 - 生体組織の近赤外線損傷の防止剤及びそれを用いた製品 - Google Patents

生体組織の近赤外線損傷の防止剤及びそれを用いた製品 Download PDF

Info

Publication number
WO2009017104A1
WO2009017104A1 PCT/JP2008/063558 JP2008063558W WO2009017104A1 WO 2009017104 A1 WO2009017104 A1 WO 2009017104A1 JP 2008063558 W JP2008063558 W JP 2008063558W WO 2009017104 A1 WO2009017104 A1 WO 2009017104A1
Authority
WO
WIPO (PCT)
Prior art keywords
infrared ray
protective agent
tissue
skin
damage
Prior art date
Application number
PCT/JP2008/063558
Other languages
English (en)
French (fr)
Inventor
Yohei Tanaka
Kiyoshi Matsuo
Original Assignee
Yohei Tanaka
Kiyoshi Matsuo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yohei Tanaka, Kiyoshi Matsuo filed Critical Yohei Tanaka
Priority to EP08791793A priority Critical patent/EP2174640A1/en
Priority to CN200880107449A priority patent/CN101795664A/zh
Priority to CA2695307A priority patent/CA2695307A1/en
Priority to US12/452,899 priority patent/US20100129426A1/en
Priority to JP2008557534A priority patent/JP4406040B2/ja
Publication of WO2009017104A1 publication Critical patent/WO2009017104A1/ja

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A61K8/027—Fibers; Fibrils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/242—Gold; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/244—Lanthanides; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/29—Titanium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • G—PHYSICS
    • G02—OPTICS
    • G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C7/00—Optical parts
    • G02C7/10—Filters, e.g. for facilitating adaptation of the eyes to the dark; Sunglasses
    • G02C7/104—Filters, e.g. for facilitating adaptation of the eyes to the dark; Sunglasses having spectral characteristics for purposes other than sun-protection
    • G—PHYSICS
    • G02—OPTICS
    • G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C7/00—Optical parts
    • G02C7/10—Filters, e.g. for facilitating adaptation of the eyes to the dark; Sunglasses
    • G02C7/108—Colouring materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/413—Nanosized, i.e. having sizes below 100 nm
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids

Abstract

　近赤外線が皮膚のみならず皮膚の組織よりも深部の組織に到達することを阻害し、近赤外線によりそれらの組織に損傷を防止したり、それに起因する様々な疾病の発症・進行や老化の促進を防止したりする生体組織の近赤外線損傷の防止剤、及びそれを用いた製品を提供する。 　生体組織の近赤外線損傷の防止剤は、近赤外線を吸収、反射、又は散乱させる近赤外線透過遮蔽剤を含有していることにより、前記近赤外線に曝露された生体の皮膚とそれよりも深部の組織とが該近赤外線で損傷されることを防止する。生体組織の近赤外線損傷の防止製品は、この防止剤を基材の少なくとも一部に塗布、吸着、接着、貼付、若しくは含有した部材を有しており、又は媒体に含有された薬剤である。
PCT/JP2008/063558 2007-07-30 2008-07-29 生体組織の近赤外線損傷の防止剤及びそれを用いた製品 WO2009017104A1 (ja)

Priority Applications (5)

Application Number Priority Date Filing Date Title
EP08791793A EP2174640A1 (en) 2007-07-30 2008-07-29 Protective agent against damage of biological tissue caused by near-infrared ray, and product comprising the same
CN200880107449A CN101795664A (zh) 2007-07-30 2008-07-29 生物组织的近红外线损伤的防止剂及使用该防止剂的制品
CA2695307A CA2695307A1 (en) 2007-07-30 2008-07-29 Protective agent against damage of biological tissue caused by near-infrared ray and product comprising the same
US12/452,899 US20100129426A1 (en) 2007-07-30 2008-07-29 Protective agent against damage of biological tissue caused by near-infrared ray and product comprising the same
JP2008557534A JP4406040B2 (ja) 2007-07-30 2008-07-29 生体組織の近赤外線損傷の防止剤及びそれを用いた製品

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007-197592 2007-07-30
JP2007197592 2007-07-30

Publications (1)

Publication Number Publication Date
WO2009017104A1 true WO2009017104A1 (ja) 2009-02-05

Family

ID=40304334

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/063558 WO2009017104A1 (ja) 2007-07-30 2008-07-29 生体組織の近赤外線損傷の防止剤及びそれを用いた製品

Country Status (7)

Country Link
US (1) US20100129426A1 (ja)
EP (1) EP2174640A1 (ja)
JP (2) JP4406040B2 (ja)
KR (1) KR20100055433A (ja)
CN (1) CN101795664A (ja)
CA (1) CA2695307A1 (ja)
WO (1) WO2009017104A1 (ja)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010262181A (ja) * 2009-05-08 2010-11-18 Nikon Corp 光学装置
WO2010142276A1 (de) * 2009-06-13 2010-12-16 Dirk Kienappel Schlafmaske/-brille und verfahren zu deren herstellung
WO2011062449A2 (ko) * 2009-11-20 2011-05-26 (주)아모레퍼시픽 무기 분말을 함유하는 화장료 조성물
KR101061289B1 (ko) * 2009-11-20 2011-08-31 (주)아모레퍼시픽 무기 분말을 함유하는 화장료 조성물
JP2012519166A (ja) * 2009-07-24 2012-08-23 コリアナ コスメティックス カンパニー リミテッド 赤外線及び紫外線同時遮断用複合粉体及びそれを用いた化粧料組成物
JP2013529681A (ja) * 2010-06-29 2013-07-22 株式会社アモーレパシフィック 老化防止用化粧料組成物
JPWO2012111834A1 (ja) * 2011-02-17 2014-07-07 バイオコーク技研株式会社 水素を発生する組成物
JP2015212271A (ja) * 2015-06-08 2015-11-26 雅夫 住田 紫外線防護剤、血流促進繊維及び血流促進繊維製品
JP2016169189A (ja) * 2015-03-13 2016-09-23 帝人株式会社 近赤外線による生体組織の損傷を防止する方法
JP2017036277A (ja) * 2015-08-13 2017-02-16 ヤー チュン ション チー ユー シエン コン スー 美容用シート
JP2017095361A (ja) * 2015-11-18 2017-06-01 花王株式会社 近赤外線防御化粧料組成物
JP2017111185A (ja) * 2015-12-14 2017-06-22 川本光学工業株式会社 近赤外線カット用眼鏡
JP2019507388A (ja) * 2016-03-04 2019-03-14 エシロール アンテルナショナルＥｓｓｉｌｏｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ 眼に関連するパラメータに対する光学フィルタの効果を定量化する数値の特定方法
WO2020138431A1 (ja) 2018-12-27 2020-07-02 花王株式会社 外用剤
WO2020138429A1 (ja) 2018-12-27 2020-07-02 花王株式会社 皮膚外用剤

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5770490B2 (ja) * 2010-03-31 2015-08-26 株式会社コーセー 水中油型乳化化粧料
US20120129425A1 (en) * 2010-11-19 2012-05-24 Lf Usa Inc. Shapewear garment
KR101716325B1 (ko) * 2011-02-28 2017-03-15 (주)아모레퍼시픽 열 차단 지수의 생성 방법
EP3124236A1 (en) 2011-06-17 2017-02-01 Fiberweb, Inc. Vapor permeable, substantially water impermeable multilayer article
PL2723568T3 (pl) 2011-06-23 2018-01-31 Fiberweb Llc Przepuszczalny dla pary, zasadniczo nieprzepuszczalny dla wody wielowarstwowy wyrób
US10369769B2 (en) 2011-06-23 2019-08-06 Fiberweb, Inc. Vapor-permeable, substantially water-impermeable multilayer article
WO2012178011A2 (en) 2011-06-24 2012-12-27 Fiberweb, Inc. Vapor-permeable, substantially water-impermeable multilayer article
FR2992858B1 (fr) 2012-07-04 2015-10-30 Oreal Composition cosmetique photoprotectrice.
WO2016171383A1 (ko) * 2015-04-22 2016-10-27 코스맥스 주식회사 적외선 차단 물질의 효능 평가 방법
WO2017034102A1 (ko) * 2015-08-26 2017-03-02 코스맥스 주식회사 근적외선 차단 효과 평가 방법
JP2021080251A (ja) * 2019-11-20 2021-05-27 花王株式会社 皮膚外用剤

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62149613A (ja) 1985-12-24 1987-07-03 Max Fuakutaa Kk 赤外線遮断物質入り化粧料
JPH07328421A (ja) * 1994-06-06 1995-12-19 Nippon Shokubai Co Ltd 無機化合物微粒子、その製造方法およびその用途
JP2005097754A (ja) * 2003-09-22 2005-04-14 Toray Ind Inc 熱可塑性繊維、布帛および繊維製品
JP2007308395A (ja) * 2006-05-16 2007-11-29 Ishihara Sangyo Kaisha Ltd 化粧料

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3009506B2 (ja) * 1991-06-10 2000-02-14 ポーラ化成工業株式会社 化粧料
US6200680B1 (en) * 1994-06-06 2001-03-13 Nippon Shokubai Co., Ltd. Fine zinc oxide particles, process for producing the same, and use thereof
JP3262098B2 (ja) * 1998-03-16 2002-03-04 住友金属鉱山株式会社 熱線遮蔽材料とこれを用いた熱線遮蔽器材並びに塗布液および熱線遮蔽膜
JP4096277B2 (ja) * 1998-09-22 2008-06-04 住友金属鉱山株式会社 日射遮蔽材料、日射遮蔽膜用塗布液、及び、日射遮蔽膜
JP4058850B2 (ja) * 1999-08-11 2008-03-12 住友金属鉱山株式会社 日射フィルター膜形成用塗布液
JP2004331509A (ja) * 2003-04-30 2004-11-25 Catalysts & Chem Ind Co Ltd 化粧料

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62149613A (ja) 1985-12-24 1987-07-03 Max Fuakutaa Kk 赤外線遮断物質入り化粧料
JPH07328421A (ja) * 1994-06-06 1995-12-19 Nippon Shokubai Co Ltd 無機化合物微粒子、その製造方法およびその用途
JP2005097754A (ja) * 2003-09-22 2005-04-14 Toray Ind Inc 熱可塑性繊維、布帛および繊維製品
JP2007308395A (ja) * 2006-05-16 2007-11-29 Ishihara Sangyo Kaisha Ltd 化粧料

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KENJI YAMAMOTO: "Kin Sekigaisen Shaheiyo Sanka Titanium no Kaihatsu", CONVERTECH, July 2004 (2004-07-01), pages 95 - 97 *
MELDRUM R.A. ET AL.: "Nanoscale spatial induction of ultraviolet photoproducts in cellular DNA by three-photon near-infrared absorption", EMBO REPORTS, vol. 4, no. 12, December 2003 (2003-12-01), pages 1144 - 1149, XP008128575 *

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010262181A (ja) * 2009-05-08 2010-11-18 Nikon Corp 光学装置
WO2010142276A1 (de) * 2009-06-13 2010-12-16 Dirk Kienappel Schlafmaske/-brille und verfahren zu deren herstellung
JP2012519166A (ja) * 2009-07-24 2012-08-23 コリアナ コスメティックス カンパニー リミテッド 赤外線及び紫外線同時遮断用複合粉体及びそれを用いた化粧料組成物
US9480632B2 (en) 2009-11-20 2016-11-01 Amorepacific Corporation Cosmetic composition containing inorganic powder
WO2011062449A3 (ko) * 2009-11-20 2011-11-10 (주)아모레퍼시픽 무기 분말을 함유하는 화장료 조성물
KR101061289B1 (ko) * 2009-11-20 2011-08-31 (주)아모레퍼시픽 무기 분말을 함유하는 화장료 조성물
WO2011062449A2 (ko) * 2009-11-20 2011-05-26 (주)아모레퍼시픽 무기 분말을 함유하는 화장료 조성물
JP2013529681A (ja) * 2010-06-29 2013-07-22 株式会社アモーレパシフィック 老化防止用化粧料組成物
JPWO2012111834A1 (ja) * 2011-02-17 2014-07-07 バイオコーク技研株式会社 水素を発生する組成物
JP6076092B2 (ja) * 2011-02-17 2017-02-08 バイオコーク技研株式会社 皮膚外用組成物
JP2016169189A (ja) * 2015-03-13 2016-09-23 帝人株式会社 近赤外線による生体組織の損傷を防止する方法
JP2015212271A (ja) * 2015-06-08 2015-11-26 雅夫 住田 紫外線防護剤、血流促進繊維及び血流促進繊維製品
JP2017036277A (ja) * 2015-08-13 2017-02-16 ヤー チュン ション チー ユー シエン コン スー 美容用シート
CN106422074A (zh) * 2015-08-13 2017-02-22 亚群生技有限公司 脉冲色光敷膜用品
JP2017095361A (ja) * 2015-11-18 2017-06-01 花王株式会社 近赤外線防御化粧料組成物
JP2017111185A (ja) * 2015-12-14 2017-06-22 川本光学工業株式会社 近赤外線カット用眼鏡
JP2019507388A (ja) * 2016-03-04 2019-03-14 エシロール アンテルナショナルＥｓｓｉｌｏｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ 眼に関連するパラメータに対する光学フィルタの効果を定量化する数値の特定方法
US11092541B2 (en) 2016-03-04 2021-08-17 Essilor International Method for determining a value quantifying the effect of an optical filter on a parameter linked to an eye
JP7053482B2 (ja) 2016-03-04 2022-04-12 エシロール アンテルナショナル 眼に関連するパラメータに対する光学フィルタの効果を定量化する数値の特定方法
WO2020138431A1 (ja) 2018-12-27 2020-07-02 花王株式会社 外用剤
WO2020138429A1 (ja) 2018-12-27 2020-07-02 花王株式会社 皮膚外用剤

Also Published As

Publication number Publication date
KR20100055433A (ko) 2010-05-26
JP2009298813A (ja) 2009-12-24
JPWO2009017104A1 (ja) 2010-10-21
US20100129426A1 (en) 2010-05-27
EP2174640A1 (en) 2010-04-14
CN101795664A (zh) 2010-08-04
JP4406040B2 (ja) 2010-01-27
CA2695307A1 (en) 2009-02-05

Similar Documents

Publication Publication Date Title
WO2009017104A1 (ja) 生体組織の近赤外線損傷の防止剤及びそれを用いた製品
WO2007130725A3 (en) Use of hmgb1 for protection against ischemia reperfusion injury
EP1575528A4 (en) TREATMENT PROTECTIVE CYTOKINS FOR THE PROTECTION, RECOVERY AND STRENGTHENING OF RESPECTIVE CELLS, TISSUE AND ORGANS
WO2006093348A3 (en) Method and composition for treating peripheral vascular diseases
WO2007089454A3 (en) Methods for enhancing skin treatments
IL172035A0 (en) Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs with an extended therapeutic window
WO2007067341A3 (en) Compositions and methods for increasing insulin sensitivity
BRPI0400350B8 (pt) sistema de lanceta para a inserção dentro de um lancetador e lancetador para produzir uma abertura na pele
WO2006138723A3 (en) Tissue coverings bearing cutomized tissue images
EP1968648A4 (en) DIAGNOSIS SYSTEM FOR THE DETECTION AND DIAGNOSIS OF SKIN CANCER
IL187522A0 (en) Lkktet and/or lkktnt compositions and methods for treating or preventing tissue deterioration, injury or damage
WO2006130026A3 (en) Protective aid
WO2007075698A3 (en) Use of benzo-fused heterocycle sulfamide derivatives as neuroprotective agents
ZA200708748B (en) Beta-2 adrenoceptor agonists for treating connective tissue diseases of the skin
FR2932990B1 (fr) Pansement de fixation et de protection d'aiguille.
WO2008054639A3 (en) Use of a catechin or polyphenol to treat ocular diseases and infection
WO2007127333A3 (en) Compositions for the treatment and prevention of eyelid swelling
TW200716194A (en) Composition for protecting human body surface
AU2003229923A1 (en) Curcumin for the prevention and/or treatment of tissue damage
WO2008012443A3 (fr) Dispositif de protection et/ou de cicatrisation
WO2004012762A3 (en) Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels
TW200738239A (en) Stable solid formulation of sertindole
WO2009126866A3 (en) Delta-tocotrienol as a radioprotective countermeasure agent
EP2077852A4 (en) AGENT CONTAINING G-CSF FOR PREVENTING AND TREATING DIABETIC PERIPHERAL NEUROPATHY
WO2007095611A3 (en) Use of benzo-fused heteroaryl sulfamide derivatives for the treatment of migraine

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200880107449.0

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 2008557534

Country of ref document: JP

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08791793

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 12452899

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2695307

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2008791793

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 20107003816

Country of ref document: KR

Kind code of ref document: A